Head and Neck Regenerative Medicine Laboratory, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Center for Evolution and Medicine, Arizona State University, Tempe, AZ, USA.
Ann Otol Rhinol Laryngol. 2024 Feb;133(2):214-223. doi: 10.1177/00034894231201016. Epub 2023 Sep 22.
Gain insights into the pathophysiology of idiopathic subglottic stenosis (iSGS) by investigating differences in transcriptome of subglottic mucosal tissue between patients with iSGS and controls, and between tracheal and subglottic tissue within patients.
RNA sequencing was conducted on biopsied mucosal samples collected from subglottic and tracheal (in-patient control) regions in iSGS patients, and from subglottis in controls. The gene expression differences were validated on a protein level by (1) staining the tissue samples obtained from a second cohort of patients and controls; and (2) in vitro functional assays using primary subglottic epithelial cells from both iSGS patients and healthy donors.
We found 7 upregulated genes in the subglottic region of iSGS patients relative to both the tracheal mucosa and subglottic region of controls. A gene ontology enrichment analysis found that the epithelial cell differentiation and cornification pathways are significant, involving specifically 3 of the genes: involucrin (), small proline rich protein 1B (), and keratin 16 (). Involvement of these pathways suggests squamous metaplasia of the epithelium. Histological analyses of epithelium in subglottic mucosal biopsies revealed squamous metaplasia in 41% of the samples from iSGS patients and in 25% from controls. Immunohistochemical evaluation of the samples presented with squamous epithelium revealed increased expression of the protein encoded by , hyperproliferative basal cells, shedding of apical layers, and accompanying lesions in iSGS compared to CTRL. Cultured primary subglottic epithelial cells from iSGS patients had higher proliferation rates compared to healthy donors and squamous metaplastic differentiation formed thinner epithelia with increased expression proteins encoded by , , and , suggesting intrinsic dysfunction of basal cells in iSGS.
Abnormal squamous differentiation of epithelial cells may contribute to the pathogenesis of iSGS. Patients having metaplastic epithelial phenotype may be sensitive to drugs that reverse it to a normal phenotype.
通过研究特发性声门下狭窄(iSGS)患者的声门下黏膜组织与对照之间以及患者的气管和声门下组织之间的转录组差异,深入了解 iSGS 的病理生理学。
对 iSGS 患者的声门下和气管(住院对照)区域以及对照的声门下采集的活检黏膜样本进行 RNA 测序。通过(1)对来自第二组患者和对照的组织样本进行染色;(2)使用来自 iSGS 患者和健康供体的原代声门下上皮细胞进行体外功能测定,在蛋白质水平上验证基因表达差异。
与对照的气管黏膜和声门下区域相比,我们发现 iSGS 患者的声门下区域有 7 个上调基因。基因本体论富集分析发现上皮细胞分化和角质化途径是显著的,具体涉及 3 个基因:包裹蛋白()、小富含脯氨酸蛋白 1B()和角蛋白 16()。这些途径的参与表明上皮的鳞状化生。声门下黏膜活检上皮组织学分析显示,iSGS 患者的样本中有 41%存在鳞状化生,而对照组中有 25%存在鳞状化生。样本的免疫组织化学评估显示,与 CTRL 相比,iSGS 中蛋白编码的表达增加,过度增殖的基底细胞,顶端层脱落和伴随的病变。与健康供体相比,iSGS 患者的原代声门下上皮细胞具有更高的增殖率,并且形成具有更高表达蛋白编码的更薄的上皮细胞,这表明 iSGS 中的基底细胞内在功能障碍。
上皮细胞的异常鳞状分化可能导致 iSGS 的发病机制。具有化生上皮表型的患者可能对逆转其正常表型的药物敏感。